A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries
Introduction Diabetes increases preventative sickness and costs healthcare and productivity. Type 2 diabetes and macrovascular disease consequences cause most diabetes-related costs. Type 2 diabetes greatly costs healthcare institutions, reducing economic productivity and efficiency. This cost of il...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2024-12-01
|
| シリーズ: | Journal of Pharmaceutical Policy and Practice |
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/20523211.2024.2322107 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|